Functional role, cellular source, and tissue distribution of rat elastase-2, an angiotensin II-forming enzyme

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 2 54-2, 2003, Pages

  Santos, Carlos F ^a   Caprio, Marcos Antonio V ^a   Oliveira, Eduardo B ^a   Salgado, Maria Cristina O ^a   Schippers, Daniela N ^b   Munzenmaier, Diane H ^b   Greene, Andrew S ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Chymostatin; Endothelium

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I DERIVATIVE; ANGIOTENSIN I [11 PROLINE 12 DEXTRO ALANINE]; CAPTOPRIL; CD31 ANTIGEN; CHYMOSTATIN; DIPEPTIDYL CARBOXYPEPTIDASE; ELASTASE; ELASTASE II; ELASTASE INHIBITOR; MESSENGER RNA; N ACETYLALANYLALANYLPROLYLLEUCYL CHLOROMETHYL KETONE; TETRADECAPEPTIDE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME SYNTHESIS; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

EID: 0038638271     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00818.2002     Document Type: Article

References (65)

1. Alexander R and Dzau VJ. Vascular biology: the past 50 years. Circulation 102: IV-112-IV-116, 2000.
2. Caldwell PR, Seegal BC, Hsu KC, Das M, and Soffer RL. Angiotensin-converting enzyme: vascular endothelial localization. Science 191: 1050-1051, 1976.
3. Carlsson PO, Berne C, and Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41: 127-133, 1998.
4. Caughey GH, Raymond WW, and Wolters PJ. Angiotensin II generation by mast cell alpha- and beta-chymases. Biochim Biophys Acta 1480: 245-257, 2000.
5. Chan WP, Fung ML, Nobiling R, and Leung PS. Activation of local renin-angiotensin system by chronic hypoxia in rat pancreas. Mol Cell Endocrinol 160: 107-114, 2000.
6. Chandrasekharan UM, Sanker S, Glynias MJ, Karnik SS, and Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 271: 502-505, 1996.
7. Chappell MC, Diz DI, and Jacobsen DW. Pharmacological characterization of angiotensin II binding sites in the canine pancreas. Peptides 13: 313-318, 1992.
8. Chappell MC, Millsted A, Diz DI, Brosnihan KB, and Ferrario CM. Evidence for an intrinsic angiotensin system in the canine pancreas. J Hypertens 9: 751-759, 1991.
9. Cornish KG, Joyner WL, and Gilmore JP. Direct evidence for the presence of a different converting enzyme in the hamster cheek pouch. Circ Res 44: 540-544, 1979.
10. Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, and Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6: 698-702, 2000.
11. Cowan KN, Jones PL, and Rabinovitch M. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 105: 21-34, 2000.
12. Del Mar EG, Largman C, Brodrick JW, Fassett M, and Geokas MC. Substrate specificity of human pancreatic elastase 2. Biochemistry 19: 468-472, 1980.
13. Dorer FE, Kahn JR, Lentz KE, Levine M, and Skeggs LT. Formation of angiotensin II from tetradecapeptide renin substrate by angiotensin-converting enzyme. Biochem Pharmacol 24: 1137-1139, 1975.
14. Dzau VJ. Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J Hypertens 7: 933-936, 1989.
15. Dzau VJ, Burt DW, and Pratt RE. Molecular biology of the renin-angiotensin system. Am J Physiol Renal Fluid Electrolyte Physiol 255: F563-F573, 1988.
16. Edwards PD, Andisik DW, Bryant CA, Ewing B, Gomes B, Lewis JJ, Rakiewicz D, Steelman G, Strimpler A, Trainor DA, Tuthill PA, Mauger RC, Veale CA, Wildonger RA, Williams JC, Wolanin DJ, and Zottola M. Discovery and biological activity of orally active peptidyl trifluoromethyl ketone inhibitors of human neutrophil elastase. J Med Chem 6: 1876-1885, 1997.
17. Faria FAC and Salgado MCO. Facilitation of noradrenergic transmission by angiotensin in hypertensive rats. Hypertension 19: SII-30-SII-35, 1992.
18. 12]angiotensin I has rapid onset vasoconstrictor activity in the cat. Am J Physiol Endocrinol Metab 273: E1059-E1064, 1997.
19. Ghiani BU and Masini MA. Angiotensin II binding sites in the rat pancreas and their modulation after sodium loading and depletion. Comp Biochem Physiol A 111: 439-444, 1995.
20. Gomez-Sanchez CE, Foecking MF, Ferris MW, Hieda HS, and Gomez-Sanchez EP. Rat mesenteric artery endothelial cells in culture secrete ET-1. Life Sci 46: 881-884, 1990.
21. Guo C, Ju H, Leung D, Massaeli H, Shi M, and Rabinovitch M. A novel vascular smooth muscle chymase is upregulated in hypertensive rats. J Clin Invest 107: 703-715, 2001.
22. Hoit BD, Shao Y, Kinoshita A, Gabel M, Husain A, and Walsh RA. Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon. J Clin Invest 95: 1519-1527, 1995.
23. Hollenberg NIK, Fisher ND, and Price DA. Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system. Hypertension 32: 387-392, 1998.
24. Hosoya K, Tomi M, Ohtsuki S, Takanaga H, Ueda M, Yanai N, Obinata M, and Terasaki T. Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat. Exp Eye Res 72: 163-172, 2001.
25. Ideishi M, Noda K, Sasaguri M, Ikeda M, and Arakawa K. Angiotensin II forming activity of vascular endothelial and smooth muscle cells. Artery 20: 95-102, 1993.
26. Inoue K, Nishimura H, Kubota J, and Kawamura K. Alternative angiotensin II formation in rat arteries occurs only at very high concentrations of angiotensin I. Hypertension 34: 525-530, 1999.
27. Juul B, Aalkjaer C, and Mulvany MJ. Contractile effects of tetradecapeptide renin substrate on rat femoral resistance vessels. J Hypertens 5: S7-S10, 1987.
28. Kifor I and Dzau VJ. Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circ Res 60: 422-428, 1987.
29. Largman C, DelMar EG, Brodrick JW, Fassett M, and Geokas MC. Inhibition of human pancreatic elastase 2 by peptide chloromethyl ketones. Biochim Biophys Acta 614: 113-120, 1980.
30. Le Trong H, Neurath H, and Woodbury RG. Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells. Proc Natl Acad Sci USA 84: 364-367, 1987.
31. Leite R, Estevão R, Resende AC, and Salgado MCO. Role of endothelium in angiotensin II formation by the rat aorta and mesenteric arterial bed. Braz J Med Biol Res 30: 649-656, 1997.
32. Leite R and Salgado MCO. Increased vascular formation of angiotensin II in one-kidney, one clip hypertensive rats. Hypertension 19: 575-581, 1992.
33. 2 in the pancreas of rodents. J Endocrinol 153: 269-274, 1997.
34. Leung PS, Chan WP, and Nobiling R. Regulated expression of pancreatic renin-angiotensin system in experimental pancreatitis. Mol Cell Endocrinol 166: 121-128, 2000.
35. Leung PS, Chan WP, Wong TP, and Sernia C. Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol 160: 13-19, 1999.
36. Lilly LS, Pratt RE, Alexander RW, Larson DM, Ellison KE, Gimbrone MA Jr, and Dzau VJ. Renin expression by vascular endothelial cells in culture. Circ Res 57: 312-318, 1985.
37. MacDonald RJ, Swift GH, Quinto C, Swain W, Pictet RL, Nikovits W, and Rutter WJ. Primary structure of two distinct rat pancreatic preproelastases determined by sequence analysis of the complete cloned messenger ribonucleic acid sequences. Biochemistry 21: 1453-1463, 1982.
38. 12)-angiotensin I. Hypertension 23: 857-60, 1994.
39. McGregor DD. The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels in rat. J Physiol 177: 21-30, 1965.
40. Miyazaki M and Takai S. Local angiotensin II-generating system in vascular tissues: the roles of chymase. Hypertens Res 24: 189-193, 2001.
41. Murakami M, Matsuda H, Kubota E, Wakino S, Honda M, Hayashi K, and Saruta T. Role of angiotensin II generated by angiotensin converting enzyme-independent pathways in canine kidney. Kidney Int 63: S132-S135, 1997.
42. Nishimoto M, Takai S, Sawada Y, Yuda A, Kondo K, Yamada M, Jin D, Sakaguchi M, Asada K, Sasaki S, and Miyazaki M. Chymase-dependent angiotensin II formation in the saphenous vein versus the internal thoracic artery. J Thorac Cardiovasc Surg 121: 729-734, 2001.
43. Nishimura H, Buikema H, Baltatu O, Ganten D, and Urata H. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system. Am J Physiol Heart Circ Physiol 275: H1307-H1312, 1998.
44. Okunishi H, Miyazaki M, Okamura T, and Toda N. Different distribution of two types of angiotensin II-generating enzymes in the aortic wall. Biochem Biophys Res Commun 149: 1186-1192, 1987.
45. Okunishi H, Oka Y, Shiota N, Kawamoto T, Song K, and Miyazaki M. Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol 62: 207-210, 1993.
46. Oliveira EB, Salgado MCO, and Turner AJ. A survey of vasoactive peptide metabolizing enzymes in the rat mesenteric arterial bed perfusate. Biochern Pharmacol 42: 1897-1904, 1991.
47. Paula CA, Sousa MV, Salgado MCO, and Oliveira EB. Purification and substrate specificity of an angiotensin converting elastase-2 from the rat mesenteric arterial bed perfusate. Biochim Biophys Acta 1388: 227-238, 1998.
48. Phillips MI, Speakman EA, and Kimura B. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 43: 1-20, 1993.
49. Rieder MJ, Roman RJ, and Greene AS. Reversal of microvascular rarefaction and reduced renal mass hypertension. Hypertension 30: 120-127, 1997.
50. Santos CF, Coelho EB, and Salgado MCO. Effect of captopril on neurally induced contraction and relaxation of mesenteric arteries of renal hypertensive rats. Can J Physiol Pharmacol 78: 469-475, 2000.
51. Santos CF, Oliveira EB, Salgado MCO, and Greene AS. Molecular cloning and sequencing of the cDNA for rat mesenteric arterial bed elastase-2, an angiotensin II-forming enzyme. J Cardiovasc Pharmacol 39: 628-635, 2002.
52. Santos CF, Paula CA, Salgado MCO, and Oliveira EB. Kinetic characterization and inhibition of the rat MAB elastase-2, an angiotensin I-converting serine protease. Can J Physiol Pharmacol 80: 42-47, 2002.
53. Stuckert-Seixas SR, Salgado MCO, and Oliveira EB. Metabolism of angiotensin I by the rat cardiac vascular bed perfusate (Abstract). FASEB J 14: A681, 2000.
54. Szilagyi CM, Sarfati P, Pradayrol L, and Morisset J. Purification, characterization and substrate specificity of rat pancreatic elastase II. Biochim Biophys Acta 1251: 55-65, 1995.
55. Tahmasebi M, Puddefoot JR, Inwang ER, and Vinson GP. The tissue renin-angiotensin system in human pancreas. J Endocrinol 161: 317-322, 1999.
56. Takai S, Shiota N, Yamamoto D, Okunishi H, and Miyazaki M. Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch. Life Sci 58: 591-597, 1996.
57. Tang SS, Stevenson L, and Dzau VJ. Endothelial renin-angiotensin pathway. Adrenergic regulation of angiotensin secretion. Circ Res 66: 103-108, 1990.
58. Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM, and Husain A. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 91: 1269-1281, 1993.
59. Urata H, Kinoshita A, Misono KS, Bumpus FM, and Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265: 22348-22357, 1990.
60. Voors AA, Pinto YM, Buikema H, Urata H, Oosterga M, Rooks G, Grandjean JG, Ganten D, and van Gilst WH. Dual pathway for angiotensin II formation in human internal mammary arteries. Br J Pharmacol 125: 1028-1032, 1998.
61. Waldeck K, Lindberg BF, Persson K, and Andersson KE. Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: a functional and biochemical study. Br J Pharmacol 121: 1081-1086, 1997.
62. Wintroub BU, Schechter NB, Lazarus GS, Kaempfer CE, and Schwartz LB. Angiotensin I conversion by human and rat chymotryptic proteinases. J Invest Dermatol 83: 336-339, 1984.
63. Wolny A, Clozel JP, Rein J, Mory P, Vogt P, Turino M, Kiowski W, and Fischli W. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ Res 80: 219-227, 1997.
64. Xiao F, Puddefoot JR, and Vinson GP. The expression of renin and the formation of angiotensin II in bovine aortic endothelial cells. J Endocrinol 64: 207-214, 2000.
65. Ziogas J and Story DF. Effect of locally generated angiotensin II on noradrenergic neuroeffector function in the rat isolated caudal artery. J Hypertens 5: S47-S52, 1987.